Insights from the Blog
GE Healthcare Life Sciences explores why Rainbow markers are a good choice when carrying out a Western blot.Continue reading
GE Healthcare Life Sciences is building a new 7,360 square meter facility in Grens, Switzerland, in the new Signy Park, for the manufacture of single use kits for the Sepax and Sefia cell processing systems. The facility will meet global regulatory requirements and is expected to be fully operational in 2022.
Overcoming one of the biggest barriers in personalized medicine